SACK1A and non-small cell lung carcinoma: It was recently proposed that FAM83A and FAM83B could serve as prognostic biomarkers and potential new therapeutic targets in NSCLC based on a study with 362 patients that quantified FAM83A and FAM83B expression by qPCR [5].